-

Atropos Health Delivers Greater Access to Real-World Evidence Through Google Cloud Marketplace

Atropos Health’s evidence-generation solutions and real-world data in the Atropos Evidence Network give customers the ability to access more personalized, real-world evidence with Google Cloud

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence (RWE) for care, today announced its availability on Google Cloud Marketplace, providing customers with increased access to relevant and timely RWE within their Google Cloud environment. Atropos Health's Artificial Intelligence (AI)-powered solutions help healthcare and life science organizations improve patient outcomes, design clinical trials, reduce time and costs for data analysis, and optimize treatment plans at the point and pace of care.

Google Cloud Marketplace lets users quickly deploy functional software packages that run on Google Cloud and allows customers to easily start up a familiar software package with services like Google Cloud Compute Engine or Cloud Storage, with no manual configuration required.

Google Cloud Marketplace customers can access Atropos Health’s portfolio of evidence-generation tools through the federated installation of GENEVA OS® in their internal cloud data environment. Customers gain access to Alexandria®, a collection of over 100,000 existing studies, including active clinical trial designs, to answer clinical questions. The existing studies in Alexandria can also be rerun on local data, generating novel new content. Customers can also choose ChatRWD®, the first generative AI application to deliver observational studies on healthcare data in minutes - a breakthrough in rapid real-world evidence.

“Atropos Health's availability enables an agent-driven workflow for evidence generation directly into the hands of researchers and clinicians," said Dr. Brigham Hyde, Co-founder and CEO of Atropos Health. “Customers can now deploy autonomous agents that generate evidence on demand and this agent-driven workflow is the key to unlocking personalized medicine at scale.”

“Bringing GENEVA OS® to Google Cloud Marketplace will help customers quickly deploy, manage, and grow the real-world evidence operating system on Google Cloud's trusted, global infrastructure," said Dai Vu, Managing Director, Marketplace & ISV GTM Programs at Google Cloud. “Atropos Health can now securely scale and support customers on their digital transformation journeys.”

For more information on Atropos Health, please visit atroposhealth.com or Google Cloud Marketplace.

About Atropos Health

Atropos Health is the developer of GENEVA OS®, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improving individual patient outcomes with data-driven care, expediting research that advances the field of medicine, and more. We aim to transform healthcare with timely, relevant real-world evidence.

To learn more about Atropos Health, visit www.atroposhealth.com or connect through LinkedIn or follow on X (Twitter) @AtroposHealth.

Contacts

Alex Millman
atropos@solcomms.co

Industry:

Atropos Health

Release Versions
English

Contacts

Alex Millman
atropos@solcomms.co

More News From Atropos Health

Atropos Health Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups

NEW YORK--(BUSINESS WIRE)--CB Insights today named Atropos Health, a leader in translating real-world clinical data into personalized real-world evidence (RWE) and insights, to its seventh annual Digital Health 50, showcasing the 50 most promising private digital health companies in the world. “The 2025 Digital Health 50 winners are high-momentum companies poised to define the next era of healthcare,” said Ellen Knapp, Principal Analyst at CB Insights. “This year’s cohort is advancing the shift...

Atropos Health Launches the Atropos Evidence™ Agent at Stanford Health Care and Collaborates with Microsoft to Improve Evidence-Based Personalized Medicine at the Point of Care

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, a pioneer in translating real-world clinical data into personalized real-world evidence (RWE) and insights, today announced the Atropos Evidence™ Agent, an expert agent in generating real-world evidence (RWE). Atropos Health is now embedding personalized evidence within the EHR at Stanford Health Care with data from ChatEHR to provide improved personalized RWE at point of care. As part of a pilot with Microsoft, Atropos Health will combine amb...

Atropos Health Enters into Strategic Collaboration to Reduce Time to Rare Disease Diagnosis with Artificial Intelligence (AI) Algorithm

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, a leader in translating real-world clinical data into personalized real-world evidence (RWE) and insights, today announced a collaboration with Novartis. Through this strategic collaboration, Atropos Health will build, train and evaluate multiple models to help streamline identification of people with a rare disease who have not yet been diagnosed, ultimately reducing time from symptom reporting to testing, diagnosis and treatment. The collabo...
Back to Newsroom